FindTrial
Sign In

Effect of Amisulpride on Electrocardiogram and Analysis of Related Risk Factors

Effect of Amisulpride on Electrocardiogram and Analysis of Related Risk Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077462
Enrollment
Unknown
Registered
2023-11-09
Start date
2023-11-15
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Low-dose group:NA
Medium-dose group:NA
High-dose group:NA

Sponsors

Second Affiliated Hospital of Xinxiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) A definite diagnosis of "schizophrenia" consistent with DSM-V or ICD-10; (2) Age 18-60 years old; (3) Amisulpride was taken as the main treatment during hospitalization; (4) The patient's complete medical record and electrocardiogram information can be retrieved.

Exclusion criteria

Exclusion criteria: (1) Large loss of ECG data; (2) Taking ß-blockers and other drugs that have significant effects on the electrocardiogram during the hospital; (3) suffering from heart-related diseases; (4) Abnormal electrocardiogram on admission.

Design outcomes

Primary

MeasureTime frame
Electrocardiogram;Related risk factors;Treatment situation;—

Countries

China

Contacts

Public ContactZhang Jie

The Second Affiliated Hospital of Xinxiang Medical University

zhangjie_xxmu@163.com+86 137 8254 4385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026